Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

CCCCCCCC
Showing 8 of 22 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in C4 THERAPEUTICS INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 1.7M shares of CCCC (C4 THERAPEUTICS INC), worth $8.1M as of 2026-Q2. The position was increased (+34.6% shares). CCCC represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$8.1M

Current Shares

1.7M

Total Value Change

+$7.8M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+34.6%
$8.1M0.0%$4.67
35
2026-Q1
Decreased
1.3M
-27.5%
$3.4M0.0%$2.95
0
2025-Q4
Increased
1.8M
+244.5%
$3.4M0.0%$1.96
43
2025-Q3
Increased
515,437
+265.4%
$1.1M0.0%$2.23
41
2025-Q2
Increased
141,056
+91.2%
$201,7100.0%$1.40
25
2025-Q1
Increased
73,782
+66.8%
$118,0510.0%$1.75
22
2024-Q4
Decreased
44,223
-11.7%
$159,2030.0%$3.64
0
2024-Q3
Increased
50,107
+13.8%
$285,6100.0%$5.89
18

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used